Ftse Mib
36.143,83
-0,34%
DAX
20.990,31
0,44%
S&P 500
5.996,66
1,00%
NASDAQ
19.630,20
1,51%
Bitcoin
102.216,44
0,18%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Autolus Therapeutics PLC (AUTL) Autolus Therapeutics PLC (AUTL) Notizie

Autolus Therapeutics PLC

AUTL
2,22
0,00 (0,00%)
18 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/1/202513:00GLOBEAutolus Therapeutics Presents Clinical Data Updates at the..
13/1/202513:00GLOBEAutolus Therapeutics Provides Business Updates and 2025..
10/12/202401:30GLOBEAutolus Therapeutics Presents Clinical Data Updates at the..
02/12/202413:00GLOBEAutolus Therapeutics Announces Publication of Data from the..
14/11/202422:32EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202422:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202415:12EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202413:54EDGAR2Form 8-K - Current report
12/11/202413:00GLOBEAutolus Therapeutics Reports Third Quarter 2024 Financial..
12/11/202412:56EDGAR2Form 8-K - Current report
08/11/202422:23GLOBEAutolus Therapeutics Announces FDA Approval of AUCATZYL®..
05/11/202415:00GLOBEAutolus Therapeutics to Present Clinical Data Updates at the..
28/10/202422:00GLOBEAutolus Therapeutics to Report Third Quarter 2024 Financial..
25/10/202422:01EDGAR2Form SC 13D/A - General Statement of Acquisition of..
16/10/202415:00GLOBEAutolus Therapeutics Presents Clinical Data Update at the..
26/9/202413:00EDGAR2Form 8-K - Current report
19/9/202414:09EDGAR2Form 8-K - Current report
19/9/202413:00GLOBEAutolus Therapeutics announces appointment of Matthias Will,..
16/9/202423:02EDGAR2Form 144 - Report of proposed sale of securities
13/9/202415:08EDGAR2Form 8-K - Current report
27/8/202413:00GLOBEAutolus Therapeutics Presents Clinical Data Update at the..
08/8/202422:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202414:27EDGAR2Form 8-K - Current report
08/8/202413:00GLOBEAutolus Therapeutics Reports Second Quarter 2024 Financial..
26/7/202413:00GLOBEAutolus Therapeutics to Report Second Quarter 2024 Financial..
14/6/202413:00GLOBEAutolus Therapeutics to Present Three Clinical Data Updates..
05/6/202422:35EDGAR2Form 8-K - Current report
03/6/202423:15EDGAR2Form 8-K - Current report
31/5/202414:00GLOBEAutolus Therapeutics presents longer-term follow-up and..
17/5/202422:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
17/5/202414:27EDGAR2Form 8-K - Current report
17/5/202413:00GLOBEAutolus Therapeutics Reports First Quarter 2024 Financial..
14/5/202416:00GLOBEAutolus Therapeutics to Present Three Clinical Data Updates..
13/5/202415:33EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
13/5/202413:23EDGAR2Form 8-K - Current report
13/5/202413:00GLOBEAutolus Therapeutics Announces Delay to its First Quarter..
24/4/202416:00GLOBEAbstract for longer-term follow-up and additional data..
23/4/202413:00GLOBEAutolus Therapeutics to Report First Quarter 2024 Financial..
02/4/202413:00GLOBEAutolus Therapeutics announces acceptance of Marketing..
01/4/202413:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
14/3/202412:00GLOBEAutolus Therapeutics Reports Full Year 2023 Financial..
12/3/202412:00GLOBEAutolus Therapeutics receives Medicines and Healthcare..
11/3/202412:00GLOBEAutolus Therapeutics announces publication in Blood Cancer..
29/2/202413:00GLOBEAutolus Therapeutics to Report Full Year 2023 Financial..
23/2/202423:28EDGAR2Form D - Notice of Exempt Offering of Securities
22/2/202413:00GLOBEAutolus Therapeutics announces publication in Nature..
21/2/202423:01EDGAR2Form SC 13D - General statement of acquisition of beneficial..
09/2/202423:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/2/202422:17EDGAR2Form 8-K - Current report
Apertura: 2,22 Min: 2,19 Max: 2,30
Chiusura: 2,22

La tua Cronologia

NASDAQ
AUTL
Autolus Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network